Recombinant kunitz protease inhibitory domain of the amyloid β-protein precursor as an anticoagulant in venovenous extracorporeal circulation in rabbits

Thrombosis and Haemostasis

Volumn 82, Issue 5, 1999, Pages 1474-1481

  Annich, Gail ^a,d   White, Tyler ^b   Damm, Deborah ^b   Zhao, Yongqiang ^c   Mahdi, Fahkri ^c   Meinhardt, Jürgen ^d   Rebello, Sam ^c   Lucchesi, Benedict ^c   Bartlett, Robert H ^d   Schmaier, Alvin H ^c,d  

^a Department of Pediatrics ^*  (United States)

^b SCIOS INC   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Amyloid protein precursor; Anticoagulant; ECC; Factor Xa inhibitor

Indexed keywords

AMYLOID PRECURSOR PROTEIN; ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 10A; FIBRINOGEN; HEPARIN; INDIUM 111; PLASMINOGEN; PREKALLIKREIN; RECOMBINANT PROTEIN; SERINE PROTEINASE INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CLOTTING TIME; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; DOG; EXTRACORPOREAL CIRCULATION; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; RABBIT; THROMBOCYTE COUNT;

EID: 0032723640     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1614858     Document Type: Article

References (21)

1. Trossaert M, Gaillard A, Commin PL, Amiral J, Vissac AM, Fressinaud E. High incidence of anti-heparin/platelet factor 4 antibodies after cardiopulmonary bypass surgery. Brit J of Haemat 1998; 101: 653-5.
2. Royston D, Bidstrup BP, Taylor KM, Sapsford RN. Effect of aprotinin on need for blood transfusion after repeat open-heart surgery. Lancet 1987; 2: 1289-91.
3. Van Nostrand WE, Wagner SL, Farrow JS, Cunningham DD. Immunopurification and protease inhibitory properties of protease nexin-2/amyloid beta-protein precursor. J Biol Chem 1990; 265: 9591-4.
4. Smith RP, Higuchi DA, Broze GJ Jr. Platelet coagulation factor XIa-inhibitor, a form of Alzheimer amyloid precursor protein. Science 1990; 248: 1126-8.
5. Schmaier AH, Dahl LD, Rozemuller AJM, Roos RAC, Wagner SL, Chung R, Van Nostrand WE. Protease nexin-2/amyloid β protein precursor. A tight-binding inhibitor of coagulation factor IXa. J Clin Invest 1993; 92: 2540-5.
6. Schmaier AH, Dahl LD, Hasan AAK, Cines DB, Bauer KA, Van Nostrand WE. Factor IXa inhibition by protease nexin-2/amyloid β-protein precursor on phospholipid vesicles and cell membranes. Biochemistry 1995; 34: 1171-8.
7. Mahdi F, Van Nostrand WE, Schmaier AH. Protease nexin-2/amyloid β-protein precursor inhibits factor Xa in the prothrombinase complex. J Biol Chem 1995; 270: 23468-74.
8. Van Nostrand WE, Schmaier AH, Farrow JS, Cunningham DD. Protease nexin-II (Amyloid β-protein precursor): A platelet α-granule protein. Science 1990; 248: 745-8.
9. Wagner SL, Siegel RS, Vedvick TS, Raschke WC, Van Nostrand WE. High level expression, purification, and characterization of the Kunitz-type protease inhibitor domain of protease nexin-2/amyloid beta-protein precursor. Biochem Biophys Res Comm 1992; 186: 1138-45.
10. Chase T Jr., Shaw E. p-Nitrophenyl-p′-guanidinobenzoate HCl: A new active site titrant for trypsin. Biochem Biophys Res Commun 1967; 29: 508-14.
11. Bieth JG. Theoretical and practical aspects of proteinase inhibition. Methods Enzymol 1995; 248: 59-84.
12. Bieth JG. In vivo significance of kinetic constants of protein proteinase inhibitors. Biochem Med 1984; 32: 387-97.
13. 111In-labeled platelets to measure survival of least dense and most dense platelets concurrently. Blood 1983; 61: 362-7.
14. Timmons S, Hawiger J. Separation of human platelets from plasma proteins including Factor VIII by a combined albumin gradient-gel filtration method using Hepes buffer. Thromb Res 1978; 12: 297-306.
15. Schmaier AH, Claypool W, Colman RW. Crotalocytin: recognition and purification of a timber rattlesnake platelet aggregating protein. Blood 1980; 56: 1013-9.
16. Rowland M, Tozer T. Clinical pharmacokinetics: concepts & applications, 2nd Edition. Lea & Febiger, Philadelphia, PA. 1989.
17. DeLa Cadena R, Scott CF, Colman RW. Evaluation of a functional microassay for determination of plasma prekallikrein. J Lab Clin Med 1987; 109: 601-7.
18. Stassen JM, Lambeir AM, Matthyssens G, Ripka WC, Nystrom A, Sixma JJ, Vermylen J. Characterization of a novel series of aprotinin-derived anticoagulants. I. In vitro and pharmacological properties. Thromb Haemost 1995; 74: 646-54.
19. Harker LA, Hanson SR, Kelly AB. Antithrombotic benefits and hemorrhagic risks of direct thrombin antagonists. Thromb Haemost 1995; 74: 464-72.
20. Gitlin SD, Deeb GM, Yann C, Schmaier AH. Intraoperative monitoring of danaparoid sodium anticoagulation during cardiovascular operations. J Vasc Surg 1998; 27: 568-75.
21. Van Nostrand WE, Schmaier AH, Siegel RS, Wagner SL, Raschke WC. Enhanced plasmin inhibition by a reactive center lysine mutant of the Kunitz-type protease inhibitor domain of the amyloid b-protein precursor. J Biol Chem 1995; 270: 22827-30.